# A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction

> **NCT06333028** · — · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 82 (actual)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** enVista Aspire EA IOLs

## Key facts

- **NCT ID:** NCT06333028
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-30
- **Primary completion:** 2025-03-13
- **Final completion:** 2025-03-13
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06333028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06333028, "A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06333028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*